Girard Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,943
| Closed | -$41K | – | 768 |
|
|
2018
Q3 | $41K | Buy |
+1,943
| New | +$41K | 0.01% | 484 |
|
|
2016
Q3 | – | Sell |
-4,080
| Closed | -$205K | – | 209 |
|
|
2016
Q2 | $205K | Sell |
4,080
-2,020
| -33% | -$101K | 0.08% | 184 |
|
|
2016
Q1 | $326K | Buy |
6,100
+822
| +16% | +$43.9K | 0.14% | 141 |
|
|
2015
Q4 | $346K | Buy |
5,278
+1,490
| +39% | +$97.7K | 0.17% | 131 |
|
|
2015
Q3 | $214K | Sell |
3,788
-849
| -18% | -$48K | 0.12% | 147 |
|
|
2015
Q2 | $274K | Buy |
4,637
+851
| +22% | +$50.3K | 0.15% | 130 |
|
|
2015
Q1 | $236K | Buy |
3,786
+1
| +0% | +$62 | 0.14% | 129 |
|
|
2014
Q4 | $218K | Buy |
+3,785
| New | +$218K | 0.14% | 133 |
|